Skip to main content

Together we are beating cancer

Donate now

Cancer Research UK-funded research

Showing 12 out of 974 results
Eithne Costello

Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important. Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important.

by Phil Prime | Interview | 12 November 2021

12 November 2021

Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials - we tell the story from discovery to translation. Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials - we tell the story from discovery to translation.

by Cancer Research UK | In depth | 5 November 2021

5 November 2021

We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment

by Phil Prime | Interview | 2 November 2021

2 November 2021

The Comprehensive Spending Review has set out the Government’s spending plans for the next three years - but what do these plans mean for our research community and its work? The Comprehensive Spending Review has set out the Government’s spending plans for the next three years - but what do these plans mean for our research community and its work?

by Oliver Buckley-Mellor | Analysis | 29 October 2021

29 October 2021

Barrett's oesophagus under the microscope

Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now. Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now.

by Harry Jenkins | Analysis | 25 October 2021

25 October 2021

We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub… We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub…

by Phil Prime | Interview | 15 October 2021

15 October 2021

We hear from Rosie Lomas - the 'Excellence in Cancer Research Nursing Award' winner - and the other shortlisted nurses about their work and the vital role they play in delivering clinical trials. We hear from Rosie Lomas - the 'Excellence in Cancer Research Nursing Award' winner - and the other shortlisted nurses about their work and the vital role they play in delivering clinical trials.

by Cancer Research UK | In depth | 13 October 2021

13 October 2021

That Cancer Conversation in a white speech bubble with a dark blue background

From groundbreaking rare cancer research to ending up on Forbes 30 under 30, we chat to Sigourney Bell about her work in the lab and her global organisation, Black in Cancer. From groundbreaking rare cancer research to ending up on Forbes 30 under 30, we chat to Sigourney Bell about her work in the lab and her global organisation, Black in Cancer.

by Cancer Research UK | Podcast | 8 October 2021

8 October 2021

This entry is part 3 of 37 in the series That Cancer Conversation
%postcontent%
Cytosponge

Professor Rebecca Fitzgerald on the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers... Professor Rebecca Fitzgerald on the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers...

by Phil Prime | Interview | 7 October 2021

7 October 2021

  • For Researchers
  • Science & Technology

Delivering the future of paediatric brain tumour therapy

Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough… Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough…

by Phil Prime | Research Feature | 7 October 2021

7 October 2021